The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Cholesterol feeding reduces nuclear forms of sterol regulatory element binding proteins in hamster liver
Abstract
Cholesterol feeding reduces the mRNAs encoding multiple enzymes in the cholesterol biosynthetic pathway and the low density lipoprotein receptor in livers of hamsters. Here we show that cholesterol feeding also reduces the levels of the nuclear NH 2 -terminal domains of sterol regulatory element binding proteins (SREBPs), which activate transcription of sterol-regulated genes. We show that livers of hamsters, like those of mice and humans, predominantly produce SREBP-2 and the 1c isoform of SREBP-1. Both are produced as membrane-bound precursors that must be proteolyzed to release the transcriptionally active NH 2 -terminal domains. Diets containing 0.1% to 1.0% cholesterol decreased the amount of nuclear SREBP-1c without affecting the amount of the membrane precursor or its mRNA, suggesting that cholesterol inhibits the proteolytic processing of SREBP-1 in liver as it does in cultured cells. Cholesterol also appeared to reduce the proteolytic processing of SREBP-2. In addition, at high levels of dietary cholesterol the mRNA encoding SREBP-2 declined and the amount of the precursor also fell, suggesting that cholesterol accumulation also may inhibit transcription of the SREBP-2 gene. The high-cholesterol diets reduced the amount of low density lipoprotein receptor mRNA by 30% and produced a more profound 70–90% reduction in mRNAs encoding 3-hydroxy-3-methylglutaryl CoA synthase and reductase. Treatment with lovastatin and Colestipol, which increases hepatic demands for cholesterol, increased the amount of SREBP-2 mRNA as well as the precursor and nuclear forms of the protein. This treatment caused a reciprocal decline in SREBP-1c mRNA and protein. Considered together, these data suggest that SREBPs play important roles in controlling transcription of sterol-regulated genes in liver, as they do in cultured cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Over-accumulation of dietary cholesterol in the liver inhibits SREBP-mediated LDLR gene transcription, leading to reduced hepatic LDLR mRNA levels in hypercholesterolemic animals.
“It is well-established that over-accumulation of dietary cholesterol in the liver inhibits sterol-regulatory element binding protein (SREBP)-mediated LDL receptor (LDLR) gene transcription leading to a reduced hepatic LDLR mRNA level in hypercholesterolemic animals.”
From A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression (2014) · cites this paper as [14]
Over-accumulation of dietary cholesterol in the liver prevents proteolytic activation of SREBPs and leads to a decline in expression of SREBP target genes, including LDLR and SREBP2 itself.
“Over-accumulation of dietary cholesterol in the liver prevents the proteolytic activation of SREBPs and leads to a decline in the expression of SREBP target genes, including LDLR and SREBP2 itself.”
From A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression (2014) · cites this paper as [14]
Cholesterol accumulation can trigger compensatory regulatory mechanisms, including reducing cholesterol synthesis and enhancing bile acid synthesis, to eliminate high cholesterol levels and attempt to return the liver to a steady state.
“In general, cholesterol accumulation can trigger compensatory regulatory mechanisms, including reducing cholesterol synthesis and enhancing bile acid synthesis, to eliminate high cholesterol levels and attempt to return the liver to a steady state.85–88”
From EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis (2025) · cites this paper as [85]
Citations
Cites
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Self-citationRegulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
Self-citationDiet-induced hypercholesterolemia in mice: prevention by overexpression of LDL receptors
Yokode, M., Hammer, R. E., Ishibashi, S., Brown, M. S., & Goldstein, J. L. (1990) · Science · doi:10.1126/science.2244210 · Cited by 175
Self-citationHorton, J. D., Cuthbert, J. A., & Spady, D. K. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116645 · Cited by 100
Self-citation
Flagged first, then by citations
Research works printed but not linked: 31
- 10.1016/0002-9343(51)90107-6 · DOI
- 10.1016/S0021-9258(18)66206-4 · DOI
- 10.1097/00005344-199601000-00012 · DOI
- 10.1016/S0022-2275(20)34361-3 · DOI
- 10.1016/S0092-8674(00)80213-5 · DOI · Paper page
- 10.1172/JCI119248 · DOI · Paper page
- 10.1172/JCI119247 · DOI
- 10.1073/pnas.92.4.935 · DOI · Paper page
- 10.1073/pnas.83.6.1916 · DOI
- J Sambrook, E F Fritsch, T Maniatis Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Lab. Press, 2nd Ed., Plainview, NY, 1989).
- 10.1016/0003-2697(87)90021-2 · DOI
- 10.1172/JCI117179 · DOI
- 10.1016/S0021-9258(17)32550-4 · DOI
- 10.1101/gad.8.16.1910 · DOI
- 10.1172/JCI118951 · DOI
- 10.1073/pnas.85.23.8998 · DOI
- 10.1093/nar/17.3.1259 · DOI
- 10.1016/S0022-2275(20)41620-7 · DOI
- 10.1006/abbi.1994.1273 · DOI
- 10.1016/S0021-9258(17)35705-8 · DOI
- 10.1038/308613a0 · DOI
- 10.1016/S0021-9258(17)39242-6 · DOI
- 10.1093/nar/12.3.1687 · DOI
- 10.1093/nar/14.6.2829 · DOI
- 10.1016/0888-7543(95)80009-B · DOI
- 10.1016/S0022-2275(20)42221-7 · DOI
- 10.1016/S0022-2275(20)37999-2 · DOI
- 10.1101/gad.10.9.1096 · DOI
- 10.1074/jbc.271.51.32689 · DOI
- 10.1073/pnas.93.3.1049 · DOI
- 10.1016/0092-8674(76)90110-0 · DOI
Cited by
Sorted by citations
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Self-citationShimomura, I., Hammer, R. E., Richardson, J. A., Ikemoto, S., Bashmakov, Y., Goldstein, J. L., & Brown, M. S. (1998) · Genes & Development · doi:10.1101/gad.12.20.3182 · Cited by 790
Self-citationJahagirdar, R., Zhang, H., Azhar, S., Tobin, J., Attwell, S., Yu, R., Wu, J., McLure, K. G., Hansen, H. C., Wagner, G. S., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.06.008 · Cited by 134
Novel role for SLPI in MOG-induced EAE revealed by spinal cord expression analysis
Mueller, A. M., Pedré, X., Stempfl, T., Kleiter, I., Couillard-Despres, S., Aigner, L., Giegerich, G., & Steinbrecher, A. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-20 · Cited by 61
Weinhofer, I. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.22.2701 · Cited by 59
Regulation of fatty acid and cholesterol synthesis: co-operation or competition?
Gibbons, G. F. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00034-1 · Cited by 51
Singh, A. B., Kan, C. F. K., Shende, V., Dong, B., & Liu, J. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m049429 · Cited by 35
EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis
Ma, F., Longo, M., Meroni, M., Bhattacharya, D., Paolini, E., Mughal, S., Hussain, S., Anand, S. K., Gupta, N., Zhu, Y., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.01.020 · Cited by 29
Metadata
- Authors
- Shimomura, I., Bashmakov, Y., Shimano, H., Horton, J. D., Goldstein, J. L., & Brown, M. S.
- Affiliations
- Department of Molecular Genetics, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Room L5.238, Dallas, TX 75235-9046
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1997-11-11
- Volume
- 94
- Issue
- 23
- Pages
- 12354-12359
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 132
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review